These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9132574)

  • 21. Characterization of human immunodeficiency virus type-1 from HIV-1 seropositive cases with undetectable viremia.
    Yang C; Li M; Cowart F; Rudolph D; Parekh B; McDougal JS; Lal RB
    J Clin Virol; 2004 Jul; 30(3):224-8. PubMed ID: 15135739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subtype G and multiple forms of A/G intersubtype recombinant human immunodeficiency virus type 1 in Nigeria.
    McCutchan FE; Carr JK; Bajani M; Sanders-Buell E; Harry TO; Stoeckli TC; Robbins KE; Gashau W; Nasidi A; Janssens W; Kalish ML
    Virology; 1999 Feb; 254(2):226-34. PubMed ID: 9986789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human immunodeficiency viruses: SIV infection in wild gorillas.
    Van Heuverswyn F; Li Y; Neel C; Bailes E; Keele BF; Liu W; Loul S; Butel C; Liegeois F; Bienvenue Y; Ngolle EM; Sharp PM; Shaw GM; Delaporte E; Hahn BH; Peeters M
    Nature; 2006 Nov; 444(7116):164. PubMed ID: 17093443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Genetic diversity of HIV infection worldwide and its consequences].
    Peeters M; Delaporte E
    Med Trop (Mars); 1999; 59(4 Pt 2):449-55. PubMed ID: 10901846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative p24 antigenaemia for monitoring response to antiretroviral therapy in HIV-1 group O-infected patients.
    Machuca A; Gutiérrez M; Mur A; Soriano V
    Antivir Ther; 1998; 3(3):187-9. PubMed ID: 10682137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predominance of HIV-1 among patients with AIDS and AIDS-related complex in Ghana.
    Brandful JA; Ampofo WK; Apeagyei FA; Asare-Bediako K; Osei-Kwasi M
    East Afr Med J; 1997 Jan; 74(1):17-20. PubMed ID: 9145571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential diagnosis of HIV type 1 group O and M infection by polymerase chain reaction and PstI restriction analysis of the pol gene fragment.
    Heyndrickx L; Janssens W; Gürtler L; Zekeng L; Loussert-Ajaka I; Vereecken K; Willems B; Coppens S; Ndumbe P; Fransen K; Saman E; Alary M; van der Groen G
    AIDS Res Hum Retroviruses; 1998 Jul; 14(11):973-7. PubMed ID: 9686643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon.
    De Oliveira F; Mourez T; Vessiere A; Ngoupo PA; Alessandri-Gradt E; Simon F; Rousset D; Plantier JC
    Retrovirology; 2017 Jan; 14(1):1. PubMed ID: 28086923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-1-O: a variant of HIV-1.
    Commun Dis Rep CDR Wkly; 1994 Jun; 4(24):109. PubMed ID: 7520315
    [No Abstract]   [Full Text] [Related]  

  • 30. HIV-1 group O infection in Cameroon, 1986 to 1998.
    Ayouba A; Mauclère P; Martin PM; Cunin P; Mfoupouendoun J; Njinku B; Souquières S; Simon F
    Emerg Infect Dis; 2001; 7(3):466-7. PubMed ID: 11384531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections.
    Schable C; Zekeng L; Pau CP; Hu D; Kaptue L; Gurtler L; Dondero T; Tsague JM; Schochetman G; Jaffe H
    Lancet; 1994 Nov; 344(8933):1333-4. PubMed ID: 7968029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Group O human immunodeficiency virus-1 infections.
    Jaffe HW; Schochetman G
    Infect Dis Clin North Am; 1998 Mar; 12(1):39-46. PubMed ID: 9494828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First case of HIV-1 group O infection in Spain.
    Soriano V; Gutiérrez M; García-Lerma G; Aguilera O; Mas A; Bravo R; Pérez-Labad ML; Baquero M; González-Lahoz J
    Vox Sang; 1996; 71(1):66. PubMed ID: 8837363
    [No Abstract]   [Full Text] [Related]  

  • 34. HIV-1 group O infection in the USA.
    Gould K; Britvan L; Dryjanski J
    Lancet; 1996 Sep; 348(9028):680-1. PubMed ID: 8782765
    [No Abstract]   [Full Text] [Related]  

  • 35. The Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon.
    Leoz M; Feyertag F; Kfutwah A; Mauclère P; Lachenal G; Damond F; De Oliveira F; Lemée V; Simon F; Robertson DL; Plantier JC
    PLoS Pathog; 2015 Aug; 11(8):e1005029. PubMed ID: 26241860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alimentary tract cytopathology in human immunodeficiency virus infection: a review of experience in Los Angeles.
    Strigle SM; Gal AA; Martin SE
    Diagn Cytopathol; 1990; 6(6):409-20. PubMed ID: 2292226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surveillance for variant strains of HIV: subtype G and group O HIV-1.
    Sullivan PS; Do AN; Robbins K; Kalish M; Subbarao S; Pieniazek D; Schable C; Afaq G; Markowitz J; Myers R; Joseph JM; Benjamin G
    JAMA; 1997 Jul 23-30; 278(4):292. PubMed ID: 9228433
    [No Abstract]   [Full Text] [Related]  

  • 38. Triple HIV-1 infection with group O and Group M of different clades in a single Cameroonian AIDS patient.
    Takehisa J; Zekeng L; Miura T; Ido E; Yamashita M; Mboudjeka I; Gürtler LG; Hayami M; Kaptue L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jan; 14(1):81-2. PubMed ID: 8989217
    [No Abstract]   [Full Text] [Related]  

  • 39. Infection with HIV-1 group O.
    Gould K
    AIDS Patient Care STDS; 1997 Dec; 11(6):399-405. PubMed ID: 11361860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surveillance for human immunodeficiency virus type 1 group O infections in the United States.
    Pau CP; Hu DJ; Spruill C; Schable C; Lackritz E; Kai M; George JR; Rayfield MA; Dondero TJ; Williams AE; Busch MP; Brown AE; McCutchan FE; Schochetman G
    Transfusion; 1996 May; 36(5):398-400. PubMed ID: 8693502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.